All Transactions - Bryan, Garnier & Co

Our transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Bryan, Garnier & Co acts as Sole Financial Advisor to Wandercraft on its $45 million Fundraising

Bryan, Garnier & Co acted as Sole Financial Advisor to the shareholders of CMN on its partnership with MBO & Co

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Headwall Photonics on the sale of the company to Arsenal Capital Partners

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Nicox on its EUR 15 million Follow-on Offering of shares and warrants

Bryan, Garnier & Co acts as Sole Financial Advisor to Aquiline Capital Partners and Elyan Partners on their potential investment in Cheops Technology

Bryan, Garnier & Co acts as Sole Financial Advisor to the sellers of Human Performance to Äleven

Bryan, Garnier & Co acts as Lead Joint Bookrunner to leading German Specialty Pharmaceuticals provider Medios AG on its EUR 93 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to leading global IoT satellite operator Astrocast on its private placement and subsequent direct listing on Euronext Growth, securing a total of CHF 45 million for the company

Bryan, Garnier & Co acts as Sole Financial Advisor to Quilvest Capital Partners and the Management of Eudonet, a European vertical CRM software provider, on the sale of the Company to Montagu Private Equity

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders and founders of Evora IT Solutions Group on the sale of the company to Allgeier SE

Bryan, Garnier & Co acts as Sole Financial Advisor to EasyVista on its acquisition of ServiceNav by Coservit

Bryan, Garnier & Co acts as Sole Global Coordinator and Joint Bookrunner on Enapter Follow-On Offering of EUR 30m

Bryan, Garnier & Co acts as Joint Bookrunner on Valneva’s Nasdaq & Euronext Paris USD 102m Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to XVIVO on its acquisition of STAR Teams, and as Joint Global Coordinator on subsequent SEK 250 million Follow-on Offering

Bryan, Garnier & Co is proud to act as Sole Financial Advisor, Sole Global Coordinator & Joint Bookrunner to Waga Energy on its EUR 126m Initial Public Offering including Strategic Investments from Vitol, CMA CGM and Viva Energy

Bryan, Garnier & Co acts as Sole Advisor and Sole Global Coordinator on Claranova’s EUR 65 million PIPE

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Elmatica in the sale of the company to NCAB Group AB

Bryan, Garnier & Co acts as Sole Financial Advisor to Cleerly on its USD 43 million Series B Fundraising

Bryan, Garnier & Co acts as Joint Bookrunner on BICO’s SEK 2 billion Follow-on Offering

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner on BALYO’s EUR 7.8 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to Agronutris on its €100 million Fundraising

Bryan, Garnier & Co acts as Sole Financial Advisor and Sole Placement Agent to leading European cybersecurity company EclecticIQ on its follow-on placement with the European Investment Bank, securing the total funding to the firm of EUR 35 million over the last 12 months

Bryan, Garnier & Co acts as Sole Financial Advisor to Parquest Capital on its minority investment in Advens

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Kea & Partners on the minority investment by Crédit Mutuel Equity and the debt operations conducted by LCL and Banque Palatine

Bryan, Garnier & Co acts as Sole Financial Advisor to Orfite and BNP Paribas Développement on the sale of Groupe GSCM to Equistone Partners Europe and BNP Paribas Développement reinvestment

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of CanPharma GmbH on the sale of the company to Health House International Ltd (ASX:HHI)

Bryan, Garnier & Co acts as Sole Financial Advisor to TVH Consulting and its shareholders on its secondary LBO with 21 Invest

Bryan, Garnier & Co acts as Sole Financial Advisor to Qred on its Private Placement pursued by Nordic Capital

Bryan, Garnier & Co acts as Sole Financial Advisor to EasyVista on its acquisition of Goverlan, Inc and its financing by Blackrock

Bryan, Garnier & Co acts as Sole Financial Advisor to Arturia on its capital and debt reorganization led by its management team and EMZ Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to the French cloud operator Oceanet Technology and its shareholders on its sale to Celeste, the InfraVia-backed French telecom operator

Bryan, Garnier & Co acts as Joint Bookrunner on Mister Spex’s EUR 326 million Initial Public Offering

Bryan, Garnier & Co acts as Sole Financial Strategic Advisor, Sole Global Coordinator and Joint Bookrunner to HDF Energy on its EUR 132.2 million Initial Public Offering including Strategic Investments from Rubis and Teréga

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner on Heidelberg Pharma’s EUR 20 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to FCDE on its acquisition of a majority stake in Didactic alongside its management team

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Abivax’s EUR 85 million Follow-on Offering & Convertible Bonds Issuance

Bryan, Garnier & Co acts as Joint Bookrunner on Swedish Stirling’s SEK 225 million Follow-on Offering

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Carbios on its EUR 114 million Publicly Marketed Follow-on Offering

Bryan, Garnier & Co advises Halma on its acquisition of PeriGen

Bryan, Garnier & Co acts as Joint Bookrunner to Valneva on its USD 108 million Nasdaq Initial Public Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Laboratoires Majorelle on the sale of a majority stake to EW Healthcare Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to French telemedicine leader Qare on its acquisition by European digital health provider HealthHero

Bryan, Garnier & Co acts as Advisor to the Shareholders of Advania on its majority sale to Goldman Sachs funds

Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 100.4 million Marketed Follow-on Offering

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner to LMK Group on its SEK 550 million Initial Public Offering

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to GenSight on its EUR 30 million Follow-on Offering

GenSight_2021_website_tombstone

Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 596 million Follow-on Offering

Azelio_website_tombstone_march2021

Bryan, Garnier & Co acts as Sole Financial Advisor to Medisys on its merger with Cityzen

Medisys_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Metsys on its growth financing led by European Digital Group

Metsys_tombstone_2

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Basilea Pharmaceutica on its CHF 46 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Ginolis Ltd on the sale of the company to BICO AB

Bryan, Garnier & Co acts as Sole Financial Advisor to the Sellers of Radon Creative to Valtech

Radon_Creative_tombstone